Header Logo

Connection

SASIREKHA RAMANI to Caliciviridae Infections

Back to Details
This is a "connection" page, showing publications SASIREKHA RAMANI has written about Caliciviridae Infections.
SASIREKHA RAMANI
Connection Strength
5.562
Caliciviridae Infections
  1. 2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 Feb 25; 99(2):e0093824.
    View in: PubMed
    Score: 0.766
  2. Birth Cohort Studies: Toward Understanding Protective Immunity to Human Noroviruses. Clin Infect Dis. 2021 01 27; 72(2):230-232.
    View in: PubMed
    Score: 0.582
  3. Influence of histo blood group antigen expression on susceptibility to enteric viruses and vaccines. Curr Opin Infect Dis. 2019 10; 32(5):445-452.
    View in: PubMed
    Score: 0.531
  4. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.450
  5. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.419
  6. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
    View in: PubMed
    Score: 0.384
  7. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.357
  8. Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Dec 16; 230(6):1376-1379.
    View in: PubMed
    Score: 0.191
  9. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.183
  10. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.175
  11. Glycan Recognition in Human Norovirus Infections. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.153
  12. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23782-23793.
    View in: PubMed
    Score: 0.142
  13. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.137
  14. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection. J Infect Dis. 2020 02 18; 221(5):739-743.
    View in: PubMed
    Score: 0.136
  15. Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol. 2019; 1576:229-247.
    View in: PubMed
    Score: 0.126
  16. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.124
  17. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.107
  18. Norovirus Gastroenteritis in a Birth Cohort in Southern India. PLoS One. 2016; 11(6):e0157007.
    View in: PubMed
    Score: 0.106
  19. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.088
  20. Exposure to human and bovine noroviruses in a birth cohort in southern India from 2002 to 2006. J Clin Microbiol. 2013 Jul; 51(7):2391-5.
    View in: PubMed
    Score: 0.085
  21. Genogroup IIb norovirus infections and association with enteric symptoms in a neonatal nursery in southern India. J Clin Microbiol. 2010 Sep; 48(9):3212-5.
    View in: PubMed
    Score: 0.070
  22. Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol. 2007 May; 79(5):544-51.
    View in: PubMed
    Score: 0.056
  23. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025 Feb 25; 99(2):e0175724.
    View in: PubMed
    Score: 0.048
  24. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.047
  25. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.038
  26. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7).
    View in: PubMed
    Score: 0.033
  27. Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther. 2017 Aug; 39(8):1537-1549.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.